ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.984,32
0,74%
S&P 500
5.948,30
-1,48%
Dow Jones
42.866,96
-1,06%
Euro vs US Dollar
1,04275
0,05%
Bitcoin
94.124,45
-1,63%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Connect Biopharma Holdings Inc (CNTB) Börsenkurse

Connect Biopharma Holdings Inc

Connect Biopharma Holdings Inc (CNTB)

NASDAQ
0,94
-0,03
( -3,09% )
Aktualisiert: 16:24:46
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,94
Gebot
0,93
Fragen
1,00
Volumen
7.565
0,93 Tagesbereich 1,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
51,797M
Handelsende
0,97
Handelsbeginn
1,00
Letzte Trade
1
@
0.93
Letzter Handelszeitpunkt
17:33:28
Finanzvolumen
US$ 7.309
VWAP
0,966165
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
55.102.954
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
1,58M
Nettogewinn
-59,5M

Über Connect Biopharma Holdings Inc

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug ... Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Grand Cayman, Cym
Gegründet
-
Connect Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CNTB. The last closing price for Connect Biopharma was US$0,97. Over the last year, Connect Biopharma shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Connect Biopharma currently has 55.102.954 shares in issue. The market capitalisation of Connect Biopharma is US$53,45 million.

CNTB Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Dezember 2024
Edgar (US Regulatory)

Attovia Therapeutics Appoints Chief Financial Officer

FREMONT, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics announced the appointment of Steven Chan as Chief Financial Officer. Mr. Chan brings extensive financial strategy and...

15 Oktober 2024
GlobeNewswire Inc.

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the “Company”), a U.S.-headquartered global clinical-stage...

10 September 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 September 2024
Edgar (US Regulatory)

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as PresidentConnect’s new management is currently evaluating...

05 September 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

02 August 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Juni 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

28 Februar 2024
Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership

13 Februar 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

13 Februar 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

CNTB - Frequently Asked Questions (FAQ)

What is the current Connect Biopharma share price?
The current share price of Connect Biopharma is US$ 0,94
How many Connect Biopharma shares are in issue?
Connect Biopharma has 55.102.954 shares in issue
What is the market cap of Connect Biopharma?
The market capitalisation of Connect Biopharma is USD 53,45M
What is the 1 year trading range for Connect Biopharma share price?
Connect Biopharma has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Connect Biopharma?
Connect Biopharma reports financial results in USD
What is the latest annual turnover for Connect Biopharma?
The latest annual turnover of Connect Biopharma is USD 1,58M
What is the latest annual profit for Connect Biopharma?
The latest annual profit of Connect Biopharma is USD -59,5M
What is the registered address of Connect Biopharma?
The registered address for Connect Biopharma is P.O. BOX 613, HARBOUR CENTRE, GEORGE TOWN, GRAND CAYMAN, KY1-1107
Which industry sector does Connect Biopharma operate in?
Connect Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AILEiLearningEngines Inc
US$ 0,5811
(259,81%)
451,45M
INTZIntrusion Inc
US$ 1,53
(240,00%)
108,92M
GTIGraphjet Technology
US$ 0,7953
(134,95%)
137,76M
LITMSnow Lake Resources Ltd
US$ 1,5112
(71,73%)
88,63M
QSIQuantum Si Inc
US$ 3,43
(59,53%)
155,89M
NEUPNeuphoria Therapeutics Inc
US$ 5,44
(-89,81%)
592,81k
PRFXPainReform Ltd
US$ 3,47
(-29,18%)
667,85k
VIRXViracta Therapeutics Inc
US$ 0,1708
(-27,93%)
2,43M
AIREreAlpha Tech Corporation
US$ 2,6499
(-25,98%)
6,12M
TOIIWOncology Institute Inc
US$ 0,007
(-25,53%)
43,3k
AILEiLearningEngines Inc
US$ 0,5811
(259,81%)
451,45M
RGTIRigetti Computing Inc
US$ 18,03
(16,77%)
199,17M
XTIAXTI Aerospace Inc
US$ 0,0399
(-0,25%)
189,29M
QSIQuantum Si Inc
US$ 3,43
(59,53%)
155,89M
GTIGraphjet Technology
US$ 0,7953
(134,95%)
137,76M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
CNTB
Connect Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten